A Prospective randomized control trial of Apixaban versus Enoxaparinas a chemoprophylaxis for venous thromboembolism in complexlower limb fractures
Phase 2
- Conditions
- Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
- Registration Number
- CTRI/2021/03/032215
- Lead Sponsor
- Praful Kilaru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All complex lower limb fractures like pelvis ,femur ,tibia .
Exclusion Criteria
-confirmed lower limb DVT pre-operatively
-coagulation abnormalities
-severe liver or kidney disease
-Head Injuries
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate deep vein thrombosis and associated pulmonary embolism in the postoperative period of lower limb complex trauma. <br/ ><br>Patient compliance and adherence with venous thromboprophylaxis medication.Timepoint: Patient will be assessed on postoperative day 2 , at 6th and 12th week.
- Secondary Outcome Measures
Name Time Method To evaluate wound dehiscence associated surgical site infection .Timepoint: wound status is evaluated along 1 month post operative period.